Clearance Summary
MBI PD-103 SL; MBI PD-103 SH received FDA 510(k) clearance under submission number K011427, sponsored by Mills Biopharmaceuticals, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2001-08-31.
- Submission: K011427
- Applicant / Sponsor: Mills Biopharmaceuticals, Inc.
- Clearance pathway: Traditional
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.5730
- Decision date: 2001-08-31
Classification & Regulation
This clearance is catalogued under FDA product code KXK and 21 CFR 892.5730, within the Radiology review panel as a Class II device.